Placebo and Nocebo Effectsin Patients With TakotsuboCardiomyopathy and Heart-HealthyControls
Not Applicable
- Conditions
- I42.88
- Registration Number
- DRKS00009296
- Lead Sponsor
- Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Klinikum rechts der Isar der Technischen Universität, München
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Women, diagnosed with TTC, and 20 volunteers (CG) free of significant coronary artery disease (vessel stenosis =30%, confirmed via
heart catheterization in the past)
TTC patients diagnosed regarding Mayo Clinic’s diagnostic criteria for akotsubo Cardiomyopathy.
Exclusion Criteria
Participants with significantly decreased ejection fraction (<55%) or low German proficiency, malignant primary disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Systolic blood pressure, diastolic blood pressure, heart rate, subjective units of distress
- Secondary Outcome Measures
Name Time Method Copeptin, cortisol<br>